DegenRx Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

DegenRx General Information

Description

Operator of a gene therapy company intended to find and develop treatments for neurodegenerative diseases. The company uses adeno-associated viral vectors to deliver genes into the brain, where they can initiate the local production of therapeutic antibodies for the treatment of central nervous system diseases such as Alzheimer's and Parkinson's disease, enabling patients to have effective treatment options for diseases such as Alzheimer's and Parkinson's.

Contact Information

Website
www.degenrx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Maidstone 48A
  • 5026 SK Tilburg
  • Netherlands
+31 013
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Maidstone 48A
  • 5026 SK Tilburg
  • Netherlands
+31 013

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DegenRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 15-Aug-2026 Completed Out of Business
1. Early Stage VC (Series A) 20-Dec-2018 Completed Pre-Clinical Trials
To view DegenRx’s complete valuation and funding history, request access »

DegenRx Patents

DegenRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023024448-A A novel amyloid-beta oligomer-specific binding molecule Pending 07-Nov-2016
AU-2017354743-A1 Novel amyloid beta oligomer specific binding molecule Inactive 07-Nov-2016
CA-3042853-A1 Novel amyloid beta oligomer specific binding molecule Pending 07-Nov-2016
EP-3535293-A1 Novel amyloid beta oligomer specific binding molecule Inactive 07-Nov-2016 C07K16/18

DegenRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DegenRx FAQs

  • When was DegenRx founded?

    DegenRx was founded in 2018.

  • Where is DegenRx headquartered?

    DegenRx is headquartered in Tilburg, Netherlands.

  • What is the size of DegenRx?

    DegenRx has 2 total employees.

  • What industry is DegenRx in?

    DegenRx’s primary industry is Biotechnology.

  • Is DegenRx a private or public company?

    DegenRx is a Private company.

  • What is DegenRx’s current revenue?

    The current revenue for DegenRx is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process